Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: Increased levels in patients with pulmonary alveolar proteinosis

Journal of Lipid Research

Volumn 45, Issue 12, 2004, Pages 2354-2360

  Meaney, Steve ^a   Bonfield, Tracey L ^b   Hansson, Magnus ^a   Babiker, Amir ^a   Kavuru, Mani S ^b   Thomassen, Mary Jane ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

27 hydroxycholesterol; Cytochrome P450 sterol 27 hydroxylase; Oxysterol; Pulmonary surfactant

Indexed keywords

26 HYDROXYCHOLESTEROL; BIOLOGICAL MARKER; CHOLESTENOIC ACID; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL DERIVATIVE; CYTOCHROME P450; MESSENGER RNA; STEROL 27 HYDROXYLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; FEMALE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CHOLESTEROL; CYTOCHROME P-450 CYP27A1; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES, ALVEOLAR; MALE; PULMONARY ALVEOLAR PROTEINOSIS; RNA, MESSENGER; STEROID HYDROXYLASES; STEROL O-ACYLTRANSFERASE;

EID: 10044281841     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400302-JLR200     Document Type: Article

References (33)

1. Lund, E., O. Andersson, J. Zhang, A. Babiker, G. Ahlborg, U. Diczfalusy, K. Einarsson, J. Sjövall, and I. Björkhem. 1996. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromh. Vasc. Biol. 16: 208-212.
2. Pikuleva, I. A., A. Babiker, M. R. Waterman, and I. Björkhem. 1998. Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways. J. Biol. Chem. 273: 18153-18160.
3. Babiker, A., O. Andersson, E. Lund, R. J. Xiu, S. Deeb, A. Reshef, E. Leitersdorf, U. Diczfalusy, and I. Björkhem. 1997. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272: 26253-26261.
4. Babiker, A., O. Andersson, D. Lindblom, J. van der Linden, B. Wiklund, D. Lütjohann, U. Diczfalusy, and I. Björkhem. 1999. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 40: 1417-1425.
5. Veldhuizen, R., K. Nag, S. Orgeig, and F. Possmayer. 1998. The role of lipids in pulmonary surfactant. Biochim. Biophys. Acta. 1408: 90-108.
6. Turley, S. D., J. M. Andersen, and J. M. Dietschy. 1981. Rates of sterol synthesis and uptake in the major organs of the rat in vivo. J. Lipid Res. 22: 551-569.
7. Voyno-Yasenetskaya, T. A., L. G. Dobbs, S. K. Erickson, and R. L. Hamilton. 1993. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc. Natl Acad. Sci. USA. 90: 4256-4260.
8. Batenburg, J. J., and H. P. Haagsman. 1998. The lipids of pulmonary surfactant: dynamics and interactions with proteins. Prog. Lipid Res. 37: 235-276.
9. Trapnell, B. C., J. A. Whitsett, and K. Nakata. 2003. Pulmonary alveolar proteinosis. N. Engl. J. Med. 349: 2527-2539.
10. Sosolik, R. C., R. R. Gammon, C. J. Julius, and L. W. Ayers. 1998. Pulmonary alveolar proteinosis. A report of two cases with diagnostic features in bronchoalveolar lavage specimens. Acta Cytol. 42: 377-383.
11. Trapnell, B. C., and J. A. Whitsett. 2002. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu. Rev. Physiol. 64: 775-802.
12. Bonfield, T. L., D. Russell, S. Burgess, A. Malur, M. S. Kavuru, and M. J. Thomassen. 2002. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am. J. Respir. Cell Mol. Biol. 27: 481-486.
13. Shibata, Y., P. Y. Berclaz, Z. C. Chroneos, M. Yoshida, J. A. Whitsett, and B. C. Trapnell. 2001. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 15: 557-567.
14. Hashimoto, S., T. Suzuki, H. Y. Dong, N. Yamazaki, and K. Matsushima. 1999. Serial analysis of gene expression in human monocytes and macrophages. Blood. 94: 837-844.
15. Babiker, A., and U. Diczfalusy. 1998. Transport of side-chain oxidized oxysterols in the human circulation. Biochim. Biophys. Acta. 1392: 333-339.
16. Thomassen, M. J., T. Yi, B. Raychaudhuri, A. Malur, and M. S. Kavuru. 2000. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect. Clin. Immunol. 95: 85-92.
17. Doumas, B., and H. Biggs. 1972. Standard Methods of Clinical Chemistry. Vol. 7. G. Cooper, editor. Academic Press, New York. 175-188.
18. Dzeletovic, S., O. Breuer, E. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
19. Applied Biosystems. 2001. Relative Quantification of Gene Expression. User Bulletin 2. Applied Biosystems, Foster City, CA. 1-36.
20. Barreda, D. R., P. C. Hanington, and M. Belosevic. 2004. Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 28: 509-554.
21. Hansson, M., E. Ellis, M. C. Hunt, G. Schmilz, and A. Babiker. 2003. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim. Biophys. Acta. 1593: 283-289.
22. Doyle, I. R., K. G. Davidson, H. A. Barr, T. E. Nicholas, K. Payne, and J. Pfitzner. 1998. Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis. Am. J. Respir. Crit. Care Med. 157: 658-664.
23. Matsuda, H., H. Hakamata, A. Miyazaki, M. Sakai, C. C. Chang, T. Y. Chang, S. Kobori, M. Shichiri, and S. Horiuchi. 1996. Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells. Biochim. Biophys. Acta. 1301: 76-84.
24. Pandak, W. M., S. Ren, D. Marques, E. Hall, K. Redford, D. Mallonee, P. Bohdan, D. Heuman, G. Gil, and P. Hylemon. 2002. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem. 277: 48158-48164.
25. Hauet, T., J. Liu, H. Li, M. Gazouli, M. Culty, and V. Papadopoulos. 2002. PBR, StAR, and PKA: partners in cholesterol transport in steroidogenic cells. Endocr. Res. 28: 395-401.
26. Soccio, R. E., and J. L. Breslow. 2003. StAR-related lipid transfer (START) proteins: mediators of intracellular lipid metabolism. J. Biol. Chem. 278: 22183-22186.
27. Kishida, T., I. Kostetskii, Z. Zhang, F. Martinez, P. Liu, S. U. Walkley, N. K. Dwyer, E. J. Blanchette-Mackie, G. L. Radice, and J. F. Strauss 3rd. 2004. Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J. Biol. Chem. 279: 19276-19285.
28. Guthmann, F., B. Harrach-Ruprecht, A. C. Looman, P. A. Stevens, H. Robenek, and B. Rustow. 1997. Interaction of lipoproteins with type II pneumocytes in vitro: morphological studies, uptake kinetics and secretion rate of cholesterol. Eur. J. Cell Biol. 74: 197-207.
29. Norlin, M., S. von Bahr, I. Björkhem, and K. Wikvall. 2003. On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. J. Lipid Res. 44: 1515-1522.
30. Pulfer, M. K., and R. C. Murphy. 2004. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J. Biol. Chem. 279: 26331-26338.
31. Agassandian, M., S. N. Mathur, J. Zhou, F. J. Field, and R. K. Mallampalli. 2004. Oxysterols trigger ABCA1-mediated basolateral surfactant efflux. Am. J. Respir. Cell Mol. Biol. 31: 227-233.
32. Fu, X., J. G. Menke, Y. Chen, G. Zhou, K. L. MacNaul, S. D. Wright, C. P. Sparrow, and E. G. Lund. 2001. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276: 38378-38387.
33. Babiker, A. 1998. Studies on a Novel Oxidative Mechanism for Elimination of Extrahepatic Cellular Cholesterol. PhD Dissertation. Stockholm, Karolinska Institute.